Fluid-Cooled RF Ablation Market Size, Share & Growth Analysis By Type (Spans Closed-Loop Irrigated Tip Catheters, Large 8-10 Mm Tip Catheters, Open-Loop Irrigated Tip Catheters, And Standard 4 Mm Tip Catheters), By Application (Pain Management, Surgery, And Others) And Regional Forecast, 2020-2027

Report Summary

Key Market Insights:

The global fluid cooled RF ablation market size is expected to witness a huge growth in the forthcoming years.

Drivers:

Increase in Demand for Neuroabulation to Drive the Market Growth

Fluid cooled RF ablation comes across as a minimally invasive neuroablative technique that is used for treating several pain syndromes. It has been used in tumor ablation and cardiac electrophysiology since the last few years, but the use in treating pain is quite recent. It needs to be noted that relief from pain using fluid cooled RF ablation is analogous to the traditional thermal radiofrequency (CT-RF), but in the former case, volume of tissue heated and the thermal lesion resulting out of it is bigger with fluid cooled RF ablation. This bigger area of the neurodestruction does increase probability of the successful denervation of the generator of pain with several/variable afferent nociceptive innervation.

The next-generation ablation products are emerging with substantial adoption of minimally-invasive procedures accompanied by growing number of ablation procedures. These factors are acting as drivers to the fluid cooled RF ablation market. The ever-increasing geriatric population is also contributing to the growth of the market. It is a known fact that minimally-invasive alternatives constitute less scarring, less pain, and do make way for speedy recovery of the patients. Also, these procedures prove to be more frugal in comparison with the conventional surgical procedures. On the whole, acceptance regarding minimally invasive surgeries is increasing due to lower rates of complication with lower mortality. This research fact comes from Stanford University Medical Center Research.

Glancing through certain facts, we get to know that more than 200,000 ablation procedures are being conducted on the patients suffering from irregular heart rhythm around the world.

Restraints:

At the same time, the fact that several therapeutic challenges are being faced in the form of product recalls can restrain the market. Moreover, as per guidelines by the EU and FDA, the nomenclature of ablation catheters is SUDs (single-use devices). Several hospitals tend to reuse and reprocess these devices due to limited reimbursements and higher per-unit cost. The reality is that cost that a surgical center/hospital incurs for reuse and reprocessing is less than 10% than cost of a new-fangled ablation device. As such, the entire procedural cost gets reduced by close to 50%. Amongst the European countries, it’s Germany allowing reuse of the SUDs (inclusive of ablation catheters). However, reprocessing of devices should be as per the regulatory guidelines.

Segmentation

The fluid cooled RF ablation market, by type, spans closed-loop irrigated tip catheters, large 8-10 mm tip catheters, open-loop irrigated tip catheters, and standard 4 mm tip catheters. By application, the market comprises pain management, surgery, and others.

Regional Segmentation:

By geography, the fluid cooled RF ablation market includes North America (US, Canada), Europe (Germany, UK, France, Spain, Italy, and the Rest of Europe), the Asia-Pacific (Japan, China, Australia, India, South Korea, and the rest of Asia-Pacific), LATAM (Mexico, Brazil, Argentina, and the rest of LATAM), and MEA (Saudi Arabia, South Africa, and the rest of MEA).

North America to Have a High Position in the Global Market

North America holds the largest market share. This could be attributed to the immediate adoption of technological upgradation in healthcare. Europe stands second on this count. Using ablation for symptomatic AF is increasing at a significant rate every single year in the UK. As per the British Heart Rhythm Society, procedural volume regarding cardiac ablation is increasing manifold every 5 years. The Asia-Pacific is expected to grow at the fastest rate between 2020 and 2030 due to improvement in healthcare infrastructure herein. MEA and LATAM are slow in this regard, but expected to catch up in the near future.

The African and Asian countries are devoid of clear guidelines regarding reuse and reprocessing of ablation catheters. Therefore, the reuse and reprocessing is very common over here. This unauthorized reuse and reprocessing is likely to accelerate risk of the blood-borne infections amongst the patients along with device malfunction.

Key Players:

The key players in the fluid cooled RF ablation market include Jude Medical (Abbott), Medtronic Plc, CONMED Corporation, Boston Scientific Corporation, AngioDynamics, Smith & Nephew Plc., Olympus Corporation, Biossense Webster, and AtriCure. Both-organic and inorganic modes of expansion are being tried out. For example – Medtronic plc, in Aug 2019, did announce approval of the US FDA to Evolut TAVR (Transcatheter Aortic Valve Replacement) system for the patients battling severe native aortic stenosis.

Biosense Webster is emphasizing on strengthening the research capabilities. Since investment of US $9.04 Bn in research, the company launched CARTO 3 System CONFIDENSE module. These technological innovations are bound to catalyse the fluid cooled RF ablation market going forward.

List Of Key Companies Profiled:

• Jude Medical (Abbott)
• Medtronic Plc
• CONMED Corporation
• Boston Scientific Corporation
• AngioDynamics, Smith & Nephew Plc.
• Olympus Corporation
• Biossense Webster